Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127323681 | 12732368 | 1 | I | 20160817 | 0 | 20160909 | 20160909 | DIR | US-FDA-350254 | FDA-CTU | 67.00 | YR | F | N | 67.50000 | KG | 20160909 | N | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127323681 | 12732368 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | Y | D | 654817 | 20190131 | 0 | 24 | DF | COATED TABLET | QD | |||
127323681 | 12732368 | 3 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | 0 | ||||||||||||
127323681 | 12732368 | 5 | C | ESTRADIOL. | ESTRADIOL | 1 | 0 | ||||||||||||
127323681 | 12732368 | 7 | C | PROMETRIUM | PROGESTERONE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127323681 | 12732368 | 1 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127323681 | 12732368 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127323681 | 12732368 | Abdominal distension | |
127323681 | 12732368 | Chest pain | |
127323681 | 12732368 | Feeling abnormal | |
127323681 | 12732368 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127323681 | 12732368 | 1 | 20160803 | 20160817 | 0 |